Abstract: . . .  NL Netherlands A Austria P Portugal FIN Finland S Sweden UK United Kingdom Page 6 d A comment is necessary with regard to the separation of the old and new Länder of Germany, which was justified when East Germany was included in the list of countries covered by Eurobarometer in autumn 1991. This distinction was retained following reunification as it frequently highlights clear-cut differences of opinion between these two territories. The abbreviation used to designate the European Union as a whole is “EU15”. The abbreviation “DNK” means “do not know”. In the sections devoted to sociodemographic variables, the reader . . .
. . .  sources of information trusted by Europeans 78 8.4 Comparison with the results of the 1996 survey 79 9. Biotechnology : a topic of discussion? 82 Overall picture (EU15 and Member States) 82 Sociodemographic variables 83 Comparison with the results of the 1996 survey 84 Page 9 REPORT Page 10 1 1. Technological progress: is an improvement in our way of life in prospect? Overall picture (EU15 and Member States) The people interviewed were asked if they thought that that their way of life would improve in the next twenty years, would not change or would deteriorate as . . .
. . .  new Länder), cloning human tissue (2.55), cloning animals (2.68) and detecting hereditary diseases (Finland, 2.14, together with Greece). The new Länder register the lowest average for the use of GM bacteria. Morally acceptable applications? When asked to come to a conclusion with regard to the moral acceptability of these seven applications, Europeans demonstrate a somewhat positive attitude towards three of them: detecting hereditary diseases, developing GM bacteria to clean spillages of oil or dangerous chemicals and introducing human genes into bacteria to produce medicines or vaccines. Two other applications are situated slightly above the midpoint, on the positive side but less marked than . . .
. . .  replaced by Austria (2.18; Greece, 2.16), and the detection of hereditary diseases, where it is replaced by Luxembourg (2.93). Page 42 33 It is also important to point out that the average achieved for the application of “developing GM bacteria” is close to “3” (2.63), which is equivalent to the response “mostly agree” and the average recorded for the use of human genes in bacteria is 2.55 (near the midpoint). Applications to be encouraged? Three of the seven applications receive a somewhat positive score at European level (equal to or above “3”, “mostly agree”), namely the detectio . . .
--3000,4,375,3221,64693